These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 30731151

  • 21. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
    Nunes PD, Pinto JF, Henriques J, Paiva AM.
    Mol Pharm; 2022 Jan 03; 19(1):51-66. PubMed ID: 34919407
    [Abstract] [Full Text] [Related]

  • 22. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion.
    Gao D, Zhu D, Zhou X, Dong S, Chen Y.
    Mol Pharm; 2023 Jan 02; 20(1):409-418. PubMed ID: 36529939
    [Abstract] [Full Text] [Related]

  • 23. Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.
    Li N, Cape JL, Mankani BR, Zemlyanov DY, Shepard KB, Morgen MM, Taylor LS.
    Mol Pharm; 2020 Oct 05; 17(10):4004-4017. PubMed ID: 32931293
    [Abstract] [Full Text] [Related]

  • 24. Dissolution Mechanisms of Amorphous Solid Dispersions: A Close Look at the Dissolution Interface.
    Deac A, Qi Q, Indulkar AS, Gao Y, Zhang GGZ, Taylor LS.
    Mol Pharm; 2023 Apr 03; 20(4):2217-2234. PubMed ID: 36926898
    [Abstract] [Full Text] [Related]

  • 25. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
    Goddeeris C, Willems T, Van den Mooter G.
    Eur J Pharm Sci; 2008 Aug 07; 34(4-5):293-302. PubMed ID: 18602800
    [Abstract] [Full Text] [Related]

  • 26. Impact of phase separation morphology on release mechanism of amorphous solid dispersions.
    Han YR, Ma Y, Lee PI.
    Eur J Pharm Sci; 2019 Aug 01; 136():104955. PubMed ID: 31199980
    [Abstract] [Full Text] [Related]

  • 27. Effect of Buffer pH and Concentration on the Dissolution Rates of Sodium Indomethacin-Copovidone and Indomethacin-Copovidone Amorphous Solid Dispersions.
    Chiang CW, Tang S, Mao C, Chen Y.
    Mol Pharm; 2023 Dec 04; 20(12):6451-6462. PubMed ID: 37917181
    [Abstract] [Full Text] [Related]

  • 28. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y, Wang S, Wang S, Liu C, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F.
    Pharm Res; 2016 Oct 04; 33(10):2445-58. PubMed ID: 27283830
    [Abstract] [Full Text] [Related]

  • 29. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H, Fussnegger B, Bodmeier R.
    Int J Pharm; 2010 May 10; 390(2):165-73. PubMed ID: 20132875
    [Abstract] [Full Text] [Related]

  • 30. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD, Lee PI.
    J Control Release; 2015 Aug 10; 211():85-93. PubMed ID: 26054795
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.
    Yang R, Zhang GGZ, Zemlyanov DY, Purohit HS, Taylor LS.
    Pharm Res; 2023 Dec 10; 40(12):2817-2845. PubMed ID: 37052841
    [Abstract] [Full Text] [Related]

  • 38. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR, Jäger N, Funke A, Mürb RK, Khinast JG, Paudel A.
    Int J Pharm; 2018 Dec 20; 553(1-2):408-421. PubMed ID: 30326284
    [Abstract] [Full Text] [Related]

  • 39. Mechanistic understanding of the phase behavior of supersaturated solutions of poorly water-soluble drugs.
    Tres F, Posada MM, Hall SD, Mohutsky MA, Taylor LS.
    Int J Pharm; 2018 May 30; 543(1-2):29-37. PubMed ID: 29572154
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.